Health Commissioner: We Are at a CRITICAL POINT

Community NewsNews
243

Translate to Spanish or other 102 languages!

Image for illustration purposes.

Mega Doctor News

- Advertisement -

Legislators had a call with Texas Department of State Health Services Commissioner John Hellerstedt to discuss COVID-19. He made it very clear we are again at a CRITICAL point. We are seeing a surge of COVID cases and hospitalizations across the nation, and Texas is NO EXCEPTION! 

The Delta variant is more transmissible, more deadly, and individuals with underlying vulnerabilities are at higher risk of severe infection and death. 95-99% of those currently hospitalized are unvaccinated. The slides below prove that the vaccine works.

We cannot eliminate this terrible and deadly disease without more individuals in our state getting the vaccine. If you have not gotten the vaccine, please get one as soon as possible. The vaccine not only protects you, it protects all of us.

- Advertisement -

Help us put COVID behind us. Find a COVID-19 vaccine near you by clicking on this link, www.vaccines.gov.

Increases in COVID-19 Hospitalizations
Increases in Pediatric Hospitalizations
 
Vaccination Decreases Hospitalizations
Vaccination Decreases Mortality
Conclusions
Vaccination Rates in SD 20

All images courtesy of Texas Health and Human Services.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
University of Houston College of Medicine to Open Direct Primary Care Clinic for the Uninsured
Next article
Neurosurgeon Jacinto I. Mañon, M.D., F.A.A.N.S, joins DHR Health Neuroscience Institute

More Articles

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.

DHR Health Burn Surgeon Urges Public to Avoid Preventable Risks

Many of the most serious burn and trauma injuries can be prevented by avoiding unnecessary risks, according to Dr. R. Dewayne Edwards, chief burn surgeon, surgical critical care and trauma surgeon at DHR Health, who said public awareness and timely medical care remain essential to improving patient outcomes.
- Advertisement -